Carbon has announced that Johnson & Johnson Innovation – JJDC has joined as an additional investor in the startup’s recent $200 million Series D funding round. Johnson & Johnson is using Carbon’s 3D printing technology to develop surgical instruments for orthopedics and other medical devices.
Last December, the rising 3D printing company Carbon raised $200 million in its Series D funding round. The substantial investment came from a variety of venture capital firms, including Baillie Gifford, Fidelity, ARCHINA Capital, Hydra Ventures (the venture arm of Adidas), GE Ventures, JSR Corporation, and Emerson Elemental.
Now, the Silicon Valley startup has revealed that yet another big headliner has joined the ranks of its latest backers. Today, Carbon announced that Johnson & Johnson Innovation –JJDC, Inc. (JJDC), the venture capital arm of the global healthcare pioneer Johnson & Johnson, has joined the impressive list of investors in the latest funding round.
The entrance of Johnson & Johnson Innovation – JJDC will allow the healthcare giant to continue innovating its research and development of medical products with Carbon’s proprietary Digital Light Synthesis technology.
The recent investment follows a strategic two-year collaboration between Carbon and Johnson & Johnson. The healthcare company has used Carbon’s groundbreaking 3D printing technology to develop surgical instruments for orthopedics and other medical devices.
“This funding is vital to the work we’re doing with leading healthcare companies to improve lives using next-gen technology, and will enable Carbon to accelerate its momentum in delivering a true, scalable digital 3D Manufacturing platform across the globe,” said Dr. Joseph DeSimone, Carbon’s CEO and Co-founder.
Even before joining Carbon’s Series D round, Johnson & Johnson has expressed increasing interest in using professional-grade 3D printing to assist patients and the medical sector. Last year, the company opened a 3D printing center at the University of Miami, and also unveiled a range of customized 3D printed surgical tools.
Meanwhile, Carbon has already amassed recognition throughout the manufacturing world through its partnership with Adidas, which has resulted in the serial production of the Futurecraft 4D footwear.
The 3D printing startup plans to use the $200 million funding round to continue its disruptive campaign to challenge injection molding. The recently acquired capital will help bring the company’s global expansion plans and product roadmap to fruition, while also supporting Carbon’s overall goal to offer mass digital production at scale.